(1 - 19 von 38
)
Guardian: Why people fall for pseudoscience (and how academics can fight back)...
Ingrained cognitive biases play a role, as does inverted snobbery about educational privilege. But we must battle on, says this scientist
Emerging Precision Medicine Powerhouse Changes Name to Increase...
www.finanznachrichten.de
LOS ANGELES, April 1, PRNewswire/ -- ImaginAb, Inc., a clinical-stage company developing in vivo molecular imaging agents based on antibody technology,...
BRIEF-Tissue Therapies appoints Christian Behrenbruch as executive...
au.investing.com
BRIEF-Tissue Therapies appoints Christian Behrenbruch as executive director
Investor Relations Center - Handelsblatt Online
ircenter.handelsblatt.com
Dr. Christian Behrenbruch, CEO von Telix, erklärte: "Die Beantragung dieser klinischen Studie in Europa ist ein wichtiger Meilenstein für das ...
Abschluss der zweiten Finanzierungsrunde von ImaginAB -...
www.krebs-nachrichten.de
ImaginAbs Projekt zur bildgestützten Diagnose von Prostatakrebs hat zu beeindruckenden klinischen Daten geführt. Wir sind davon überzeugt, dass unser...
Vital Images Expands Relationship With Mirada Solutions and Launches...
www.finanznachrichten.de
MINNEAPOLIS, Nov PRNewswire-FirstCall/ -- Vital Images, Inc. , a leading provider of advanced visualization software, has signed non-exclusive strategic...
FIBRON TECHNOLOGIES: US conductive polymer producer establishes...
www.plasteurope.com
Plasteurope.com is a business information platform for the European plastics industry.
ImaginAb Raises $12.5M for Antibody Fragment PET Imaging Platform
www.genengnews.com
Firm will use funds to speed clinical development of cancer and immunology programs.
Imaging System Looks Good In Funding Round | Los Angeles Business...
labusinessjournal.com
ImaginAb was founded in by UCLA faculty members Drs. Robert Reiter and Anna Wu, and former professor Dr. Christian Behrenbruch.
Leading judge takes out top distinguished alumni award - Monash...
www.monash.edu
Faculty of Engineering: Professor Christian Behrenbruch (BE (Elec&Comp) (Hons) 1998), is recognised internationally for his ...
Oxford BioMedica and ImaginAb Ally to Develop 5T4 Antibody-Based...
www.genengnews.com
ImaginAb says initial focus will be on PET imaging agent for ovarian cancer.
Telix Group Expands Prostate Imaging Capability through ININ...
www.efe.com
Telix Group CEO Dr. Christian Behrenbruch stated, “In the US and EU where PET infrastructure is well-developed, PET-based nuclear ...
Radically simple technique developed to grow conducting polymer thin...
phys.org
Fibron's CEO, Christian Behrenbruch, said "working with UCLA to develop this technology has been a win-win. It enables us to access ...
Pourquoi les gens craquent-ils pour la pseudoscience? - Sputnik France
fr.sputniknews.africa
Le Guardian démystifie la popularité de la pseudoscience à notre époque si rationnelle, et explique comment elle nous rend vulnérables.
Telix files study for kidney cancer imaging in Europe - Biotech
biotechdispatch.com.au
According to Telix CEO Dr Christian Behrenbruch, “The filing of this clinical trial in Europe marks a major operational milestone for the ...
Yubulyawan Dreaming Project :: NEWS
ydproject.com
... Brian Breslin Taylor,Sally Madden, Laurie & Cat Orman, Christian Behrenbruch, Jane McCarthy, Ben Baker, Ellen Taylor, Susan Lounsbury, Worlds of Music, ...
Sectra signs co-operation agreement with Mirada Solutions - Sectra
news.cision.com
Sectra increases customer benefit through new partnership: Sectra signs co-operation agreement
sortiert nach Relevanz / Datum